BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cartagenia n.v. Signs 2 New US Customers and Appoints Drew Arnold as VP North America


3/21/2012 9:10:29 AM

Leuven, 21 March 2012 – Cartagenia, the global leader in supplying diagnostic knowledge, analytic software and database systems to genetic labs and clinicians, today announced that – following 2 additions to its US customer list - it is opening its first North American office in Boston, MA. Heading the new office will be Drew Arnold who has been appointed VP Sales and Business Development North America. Drew – with a 15-year history of sales and business development in the life sciences – joins Cartagenia from GenomeQuest, Inc. where he headed its global sales team. As Drew puts it: “I am excited about joining Cartagenia and look forward to growing the North American customer base. Cartagenia products have enjoyed rapid adoption in Europe and are the only analysis solutions specifically built for automating genetic interpretation from both array CGH- and sequence-based variant testing, linking genotype to phenotype.”

With industry-leading technologies in array CGH and next generation sequencing (NGS), Cartagenia already counts a number of North American genetic labs among its customers and is closely collaborating with the International Standards for Cytogenomic Arrays (ISCA) Consortium. In addition, Cartagenia has recently signed major commercial contracts with a number of leading US diagnostic and genetics labs including GeneDX, Gaithersburg, MD and Los Angeles Children's Hospital, Los Angeles, CA.

To support the increasing number of customers among US and Canadian genetic labs, clinicians and hospitals, Cartagenia felt it was necessary to add a North American office. As Herman Verrelst, Cartagenia’s CEO puts it, “We want to duplicate our European success in North America. We envision Cartagenia products rapidly growing in both the commercial and research markets in the US and Canada. To foster that growth we need to be closer to our customers, with Cartagenia providing them with local support and services. And we feel that Drew is just the right person to lead this effort.”

About Cartagenia

Cartagenia supplies diagnostic knowledge, software and database systems, and related services to genetic labs and clinicians, enabling them to perform clinically relevant genetic analyses quickly and efficiently, and offer patients and carers high-quality genetic interpretation and counselling.

(www.cartagenia.com)

Contact:

CARTAGENIA

Herman Verrelst

CEO Cartagenia

Technologielaan 3

3001 Leuven

T +32 16 40 40 66

E herman.verrelst@cartagenia.com

www.cartagenia.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES